Geneva Advisors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 93 filers reported holding IMMUNOMEDICS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geneva Advisors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2017$279,000
+37.4%
31,635
+0.6%
0.01%
+25.0%
Q1 2017$203,000
+62.4%
31,435
-7.4%
0.00%
+100.0%
Q4 2016$125,000
+13.6%
33,9350.0%0.00%0.0%
Q3 2016$110,000
+39.2%
33,9350.0%0.00%0.0%
Q2 2016$79,000
-24.0%
33,935
-18.1%
0.00%0.0%
Q1 2016$104,000
-18.8%
41,435
-0.3%
0.00%0.0%
Q4 2015$128,00041,5550.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders